Published in Reprod Biomed Online on April 01, 2006
Integrity of human sperm DNA assessed by the neutral comet assay and its relationship to semen parameters and clinical outcomes for the IVF-ET program. Clin Exp Reprod Med (2011) 0.87
Follicular steroid hormones as markers of oocyte quality and oocyte development potential. J Hum Reprod Sci (2014) 0.85
A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome. Asian J Androl (2016) 0.80
Relation of cumulus cell status with single oocyte maturity, fertilization capability and patient age. J Reprod Infertil (2014) 0.78
Measuring Sperm DNA Fragmentation and Clinical Outcomes of Medically Assisted Reproduction: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.76
Multifactorial analysis of the follicular environment is predictive of oocyte morphology in cattle. J Reprod Dev (2013) 0.75
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Fertility and ageing. Hum Reprod Update (2005) 2.68
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update (2005) 2.12
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod (2005) 2.02
Post-neonatal health and development of children born after assisted reproduction: a systematic review of controlled studies. Eur J Obstet Gynecol Reprod Biol (2006) 1.92
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update (2006) 1.76
Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer (2000) 1.70
Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins. Hum Reprod (1986) 1.60
Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet (2001) 1.54
Laparoscopic nerve-sparing radical hysterectomy: description of the technique and patients' outcome. Gynecol Oncol (2010) 1.53
Heterotopic pregnancy in a spontaneous cycle: do not forget about it! Eur J Obstet Gynecol Reprod Biol (1999) 1.49
No impact of cryopreservation and thawing on embryo developmental potential--one more example for the problems of retrospective, non-controlled data. Hum Reprod (1998) 1.47
Atypical ductus venosus blood flow pattern in fetuses with severe tricuspid valve regurgitation. Ultrasound Obstet Gynecol (2005) 1.44
Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects. Fetal Diagn Ther (2006) 1.41
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update (2007) 1.39
[Prevention of complications in twin gestations and pregnancies after assisted reproduction]. Z Geburtshilfe Neonatol (2010) 1.39
Debate. Assisted reproductive techniques - are we avoiding the genetic issues? Hum Reprod (1996) 1.38
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online (2006) 1.37
GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update (2006) 1.32
Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod (2006) 1.21
Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod (1999) 1.20
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Differences in membrane properties between unfertilised and fertilised single rabbit oocytes demonstrated by electro-rotation. Comparison with cells from early embryos. Biochim Biophys Acta (1989) 1.16
Distribution of ABO and Rh blood groups in Greece: an update. Int J Immunogenet (2011) 1.12
Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod (1998) 1.11
Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod (1995) 1.09
Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod (2001) 1.07
[Use of fibrin glue in vesico-vaginal fistulas after gynecologic treatment]. Zentralbl Gynakol (1996) 1.07
Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol (2001) 1.06
Polyspermy in in vitro fertilization of human oocytes: frequency and possible causes. Ann N Y Acad Sci (1985) 1.06
Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod (2007) 1.05
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril (2007) 1.04
Approaches to improve the diagnosis and management of infertility. Hum Reprod Update (2009) 1.04
Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod (2004) 1.03
Clinical use of a pronuclear stage score following intracytoplasmic sperm injection: impact on pregnancy rates under the conditions of the German embryo protection law. Hum Reprod (2000) 1.03
The forgotten child--a case of heterotopic, intra-abdominal and intrauterine pregnancy carried to term. Hum Reprod (1999) 1.02
Results of cytogenetic analysis in men with severe subfertility prior to intracytoplasmic sperm injection. Hum Reprod (1996) 1.02
ESHRE guidelines for good practice in IVF laboratories. Committee of the Special Interest Group on Embryology of the European Society of Human Reproduction and Embryology. Hum Reprod (2000) 1.01
Use of frozen-thawed testicular sperm for intracytoplasmic sperm injection. Fertil Steril (2000) 0.98
Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online (2004) 0.97
Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum Reprod (2002) 0.96
Comparison of cryopreservation of supernumerary pronuclear human oocytes obtained after intracytoplasmic sperm injection (ICSI) and after conventional in-vitro fertilization. Hum Reprod (1996) 0.96
Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update (1999) 0.95
Electro-rotation of mouse oocytes: single-cell measurements of zona-intact and zona-free cells and of the isolated zona pellucida. Biochim Biophys Acta (1987) 0.95
DNA damage of human spermatozoa in assisted reproduction: origins, diagnosis, impacts and safety. Reprod Biomed Online (2007) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Oocyte cryopreservation for age-related fertility loss. Hum Reprod (2012) 0.95
Cryopreservation of human oocytes. Hum Reprod (1987) 0.94
Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet (2001) 0.94
Experience with the elective transfer of two embryos under the conditions of the german embryo protection law: results of a retrospective data analysis of 2573 transfer cycles. Hum Reprod (2000) 0.94
Current aspects of blastocyst cryopreservation. Reprod Biomed Online (2008) 0.94
Transfer technique and catheter choice influence the incidence of transcervical embryo expulsion and the outcome of IVF. Hum Reprod (1999) 0.93
Laparoscopic management of ovarian dermoid cysts. A series of 83 cases. Arch Gynecol Obstet (2002) 0.93
Transvaginal sonography of the endometrium during ovum pickup in stimulated cycles for in vitro fertilization. J Ultrasound Med (1989) 0.93
Demonstration of fetal coronary blood flow by Doppler ultrasound in relation to arterial and venous flow velocity waveforms and perinatal outcome--the 'heart-sparing effect'. Ultrasound Obstet Gynecol (1997) 0.93
Transvaginal sonographically guided oocyte retrieval for in-vitro fertilization. Hum Reprod (1988) 0.92
The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist. Fertil Steril (1990) 0.92
Introduction of LHRH-antagonists into the treatment of gynaecological disorders. Hum Reprod (1994) 0.91
Chlorinated hydrocarbon content of fetal and maternal body tissues and fluids in full term pregnant women: a comparison of Germany versus Tanzania. Hum Reprod (1992) 0.91
Accumulation of pollutants in the genital tract of sterility patients. J Clin Chem Clin Biochem (1990) 0.91
Diagnosis and treatment options of vulvar cancer: a review. Arch Gynecol Obstet (2011) 0.91
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod (2005) 0.91
Luteal phase following oocyte aspiration, in vitro fertilization, and embryo transfer in clomid/HCG-stimulated cycles. Arch Gynecol (1982) 0.91
Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update (2009) 0.90
Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies. Arch Gynecol Obstet (2004) 0.90
Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod (1998) 0.90
Interactions of insulin-like growth factor-I, insulin and estradiol with GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol (2001) 0.90
Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? Hum Reprod (2002) 0.90
The diagnostic dilemma of minimal and mild endometriosis under routine conditions. J Am Assoc Gynecol Laparosc (2003) 0.90
Prospective evaluation of the systemic immune response following abdominal, vaginal, and laparoscopically assisted vaginal hysterectomy. Surg Endosc (2001) 0.89
Hydrosalpinx and IVF: assessment of treatments implemented prior to IVF. Reprod Biomed Online (2007) 0.89
The value of uterine artery Doppler ultrasound in the prediction of severe complications in a risk population. Arch Gynecol Obstet (2004) 0.88
A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol (2007) 0.88
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. Hum Reprod (2014) 0.88
Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol (1995) 0.88
Human oocyte cryopreservation: past, present and future. Reprod Biomed Online (2006) 0.88
[Pregnancies obtained by oocyte aspiration, in vitro fertilization, and embryo transfer during clomid/HCG stimulated cycles (author's transl)]. Geburtshilfe Frauenheilkd (1981) 0.88
Serum leptin concentrations throughout the menstrual cycle. Arch Gynecol Obstet (2000) 0.87
ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. Hum Reprod (2013) 0.87
Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches. Neurosci Res (2006) 0.87
Endometrial stromal sarcomas--a retrospective analysis of 11 patients. Anticancer Res (2006) 0.86
Comparison between chromatin condensation and morphology from testis biopsy extracted and ejaculated spermatozoa and their relationship to ICSI outcome. Hum Reprod (1999) 0.86